The second anniversary of the Early Drug Diversion Initiative (EDDI) in New South Wales (NSW) prompts renewed calls for substantial reform in drug laws. Launched on February 29, 2024, EDDI was designed to mitigate the harms associated with current drug legislation. Advocacy groups argue that progress has been inadequate, highlighting the need for immediate action.
Alice Salomon, head of advocacy at Uniting NSW.ACT, expressed disappointment regarding the initiative’s impact. “Many had hoped for better outcomes for loved ones dealing with drug dependency,” she stated. Despite the NSW Government’s commitment to reform, articulated in its response to the NSW Drug Summit 14 months ago, tangible changes remain elusive.
Advocates are eager for the NSW Government to improve the EDDI framework. Salomon emphasized the necessity of incorporating feedback from the alcohol and other drug (AOD) sector, individuals with lived experiences, and legal professionals. “The same principles should guide any redesign of EDDI,” she added.
She further asserted that personal drug use ought to be treated as a health issue rather than a criminal one. Salomon outlined several recommended changes, including the abolition of police discretion, the removal of the strike system, and adjustments to eligibility criteria. “Everyone should have access to this diversion scheme, particularly First Nations peoples, economically disadvantaged individuals, youth, and those with prior convictions,” she said.
EDDI’s effectiveness is awaiting evaluation by the Bureau of Crime Statistics and Research (BOCSAR), which is expected to yield critical data shortly. Salomon urged the government to engage with the AOD sector and legal services to inform the best-practice model for EDDI. “The government must expedite this consultation and necessary reforms,” she insisted.
Research from the Drug Policy Modelling Program (DPMP) at UNSW indicates low engagement with the scheme among police, as enforcement disproportionately targets certain drugs and demographics. “Preliminary findings reveal that EDDI is more accessible for users of cocaine or MDMA and less so for First Nations communities,” Salomon noted. This disparity suggests a system that privileges certain groups over others.
Advocates argue for evidence-based, inclusive diversion programs that promise better outcomes for all individuals involved. “Everyone should be eligible for diversion under EDDI for possessing small amounts of drugs for personal use,” Salomon asserted. Surveys consistently show widespread community support for this approach.
Uniting operates the Medically Supervised Injecting Centre and has championed the Fair Treatment campaign for equitable drug laws for more than seven years. As the EDDI reaches this milestone, the focus remains on ensuring that reforms align with the principles of fairness and accessibility for all community members.
